Amplyx, Now A Subsidiary Of Pfizer Inc.

Amplyx, Now A Subsidiary Of Pfizer Inc. company information, Employees & Contact Information

Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today’s therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx’s leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions. For more information on Amplyx, please visit our website at www.amplyx.com

Company Details

Employees
18
Address
12730 High Bluff Drive,
Phone
118583484458
Email
in****@****lyx.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
amplyx.com
HQ
San Diego, CA
Looking for a particular Amplyx, Now A Subsidiary Of Pfizer Inc. employee's phone or email?

Amplyx, Now A Subsidiary Of Pfizer Inc. Questions

News

Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million - PR Newswire

Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million PR Newswire

Pfizer buys Amplyx to expand drug-resistant treatment portfolio - Reuters

Pfizer buys Amplyx to expand drug-resistant treatment portfolio Reuters

Treatment for Cryptococcosis Gets FDA’s Orphan Drug Designation - Infectious Disease Advisor

Treatment for Cryptococcosis Gets FDA’s Orphan Drug Designation Infectious Disease Advisor

Pfizer buys infectious disease biotech Amplyx - BioPharma Dive

Pfizer buys infectious disease biotech Amplyx BioPharma Dive

Pfizer buys Amplyx to grow infectious disease pipeline - Fierce Biotech

Pfizer buys Amplyx to grow infectious disease pipeline Fierce Biotech

Pfizer acquires Amplyx Pharmaceuticals to advance anti-infectives pipeline - Pharmaceutical Technology

Pfizer acquires Amplyx Pharmaceuticals to advance anti-infectives pipeline Pharmaceutical Technology

Pfizer buys antifungal maker Amplyx Pharmaceuticals - Chemical & Engineering News

Pfizer buys antifungal maker Amplyx Pharmaceuticals Chemical & Engineering News

Amplyx Announces Positive Top-line Data in Phase 2 Clinical Trial of Novel Antifungal Fosmanogepix - BioSpace

Amplyx Announces Positive Top-line Data in Phase 2 Clinical Trial of Novel Antifungal Fosmanogepix BioSpace

Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics - PMLiVE

Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics PMLiVE

Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix - PR Newswire

Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix PR Newswire

Basilea continues pipeline fill-up by paying Pfizer $37M for Amplyx antifungal - Fierce Biotech

Basilea continues pipeline fill-up by paying Pfizer $37M for Amplyx antifungal Fierce Biotech

FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications - PR Newswire

FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications PR Newswire

Pfizer cuts 3 assets as R&D spend drops 24% in Q4 - Fierce Biotech

Pfizer cuts 3 assets as R&D spend drops 24% in Q4 Fierce Biotech

Top Amplyx, Now A Subsidiary Of Pfizer Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant